{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:03:48Z","timestamp":1785305028942,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1994,12,1]],"date-time":"1994-12-01T00:00:00Z","timestamp":786240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Investig"],"published-print":{"date-parts":[[1994,12]]},"DOI":"10.1007\/bf00577749","type":"journal-article","created":{"date-parts":[[2004,11,20]],"date-time":"2004-11-20T13:52:27Z","timestamp":1100958747000},"page":"1027-1029","source":"Crossref","is-referenced-by-count":16,"title":["Insulin-dependent diabetes mellitus following pentamidine therapy in a patient with AIDS"],"prefix":"10.1007","volume":"72","author":[{"given":"U.","family":"Liegl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. D.","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diacare.16.6.931","volume":"16","author":"NN Abourizk","year":"1993","unstructured":"Abourizk NN, Lyons RW, Madden GM (1993) Transient state of NIDDM in a patient with AIDS. Diabetes Care 16:931?933","journal-title":"Diabetes Care"},{"key":"CR2","first-page":"262","volume":"19","author":"R Assan","year":"1993","unstructured":"Assan R, Assan D, Delaby J, Debussche X, Toublanc M (1993) Pentamidine-induced dysglycaemia: experimental models in the rat. Diabetes Metab 19:262?272","journal-title":"Diabetes Metab"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00283144","volume":"28","author":"D Boillot","year":"1985","unstructured":"Boillot D, Veld P in't, Sai P, Feutren G, Gepts W, Assan R (1985) Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro. Diabetologica 28:359?364","journal-title":"Diabetologica"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000441-198903000-00009","volume":"297","author":"RJ Collins","year":"1989","unstructured":"Collins RJ, Pien FD, Houk JH (1989) Case report: Insulin-dependent diabetes mellitus associated with pentamidine. Am J Med Sci 297:174?175","journal-title":"Am J Med Sci"},{"key":"CR5","first-page":"242","volume":"33","author":"LG Goa","year":"1987","unstructured":"Goa LG, Campoli-Richards DM (1987) Pentamidine Isethionate. A review of its antiprotozoal activity, pharmakokinetic properties and therapeutic use in pneumocystis carinii pneumonia. Drugs 33:242?258","journal-title":"Drugs"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0046-8177(91)90185-R","volume":"22","author":"L Hauser","year":"1991","unstructured":"Hauser L, Sheehan P, Simpkins H (1991) Pancreatic pathology in pentamidine-induced diabetes in acquired immunodeficiency syndrome patients. Hum Pathol 22:926?929","journal-title":"Hum Pathol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0163-4453(91)90926-J","volume":"22","author":"TE Herchline","year":"1991","unstructured":"Herchline TE, Plouffe JF, Para MF (1991) Diabetes mellitus presenting with ketoacidosis following pentamidine therapy in patients with acquired immunodeficiency syndrome. J Infect 22:41?44","journal-title":"J Infect"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0035-9203(84)90289-X","volume":"78","author":"TK Jha","year":"1984","unstructured":"Jha TK, Sharma VK (1984) Pentamidine-induced diabetes mellitus. Trans R Soc Trop Med 78:252?253","journal-title":"Trans R Soc Trop Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/diab.29.12.971","volume":"29","author":"JH Karam","year":"1980","unstructured":"Karam JH, Lewitt PA, Young CW, Nourlain RE, Frankel BJ, Fujia H, Freedman ZR, Grodsky GM (1980) Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 29:971?978","journal-title":"Diabetes"},{"key":"CR10","first-page":"602","volume":"149","author":"MW Lambertus","year":"1988","unstructured":"Lambertus MW, Murthy AR, Nagami P, Goetz MB (1988) Diabetic ketoacidosis following pentamidine therapy in a patient with the aquired immunodeficiency syndrome. 149:602?604","journal-title":"Diabetic ketoacidosis following pentamidine therapy in a patient with the aquired immunodeficiency syndrome"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00282521","volume":"25","author":"P Sai","year":"1983","unstructured":"Sai P, Boillot D, Boitard C, Debray-Sachs M, Reach G, Assan R (1983) Pentamidine, a new diabetogenic drug in laboratory rodents. Diabetologica 25:418?423","journal-title":"Diabetologica"},{"key":"CR12","first-page":"245","volume":"85","author":"R Terlinden","year":"1990","unstructured":"Terlinden R, R\ufffdmer A (1990) Pharmakokinetik und Toxikokinetik von Pentamidin in der Ratte nach intraven\ufffdser und Aerosolgabe. Med Klin 85:245?247","journal-title":"Med Klin"},{"key":"CR13","first-page":"236","volume":"85","author":"F Wingen","year":"1990","unstructured":"Wingen F (1990) Autoradiographische Untersuchung der Organverteilung von 14C-Pentamidin nach intraven\ufffdser und inhalativer Verabreichung an Ratten. Med Klin 85:236?244","journal-title":"Med Klin"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1445-5994.1991.tb04702.x","volume":"21","author":"G Wood","year":"1991","unstructured":"Wood G, Hogan P, Wetzig N, Whitby M (1991) Survival from pentamidine induced pancreatitis and diabetes mellitus. Aust NZ J Med 21:341?342","journal-title":"Aust NZ J Med"}],"container-title":["The Clinical Investigator"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00577749.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00577749\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00577749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T12:46:48Z","timestamp":1554814008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00577749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1994,12]]}},"alternative-id":["BF00577749"],"URL":"https:\/\/doi.org\/10.1007\/bf00577749","relation":{},"ISSN":["0941-0198","1432-1440"],"issn-type":[{"value":"0941-0198","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,12]]}}}